Sapere Bio

Raleigh, United States Founded: 2013 • Age: 13 yrs
Non-invasive biomarker tests are developed to measure cellular aging.

About Sapere Bio

Sapere Bio is a company based in Raleigh (United States) founded in 2013 by Norman Sharpless and Natalia Mitin. Sapere Bio has raised $500 thousand across 5 funding rounds from investors including HHS. Sapere Bio operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others.

  • Headquarter Raleigh, United States
  • Founders Norman Sharpless, Natalia Mitin
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website saperebio.com
  • Social LinkedIn
Key Metrics
  • Total Equity Funding
    $500K (USD)

    in 5 rounds

  • Latest Funding Round
    $500K (USD), Seed

    Jun 2024

  • Investors

Funding Insights of Sapere Bio

Sapere Bio has successfully raised a total of $500K across 5 strategic funding rounds. The most recent funding activity was a Seed round of $500 thousand completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $500,000
  • Total Rounds 5
  • Last Round Seed β€” $500,000
  • First Round $121,635

    (Sep 2014)

  • Investors Count 1

All 5 funding rounds of Sapere Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2024$500,000Seed––
–
Sep 2021$1.93MGrant––
Sep 2018$1.77MGrant––
Jul 2015$299,648Grant––
Sep 2014$121,635Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Sapere Bio

Sapere Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov-
Premium access

Investor details for Sapere Bio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Sapere Bio

2 people are tracked at Sapere Bio (2 in leadership).

NameRoleGroup
Norman Sharpless
Co-FounderLeadership
Natalia Mitin
Co-Founder & CEOLeadership
Premium access

Complete people profiles for Sapere Bio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Sapere Bio

3 dated milestones of Sapere Bio across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sapere Bio is founded.
  2. Funding First funding round of $122K.
  3. Funding Latest funding round, Seed, of $500K.

Competitors of Sapere Bio

Sapere Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
guardanthealth.com2012Redwood, United States$557.5M1,351
Digital sequencing technology for cancer detection is developed.
natera.com2004Redwood, United States$152.1M3,293
Developer of cell-free DNA testing for oncology, women’s health, and organ health
foundationmedicine.com2010Cambridge, United States$96.5M1,707
Genomics-based diagnostic tests for cancer are provided.
archerdx.com2013Boulder, United States$152.6M429
Molecular cancer diagnostic products are developed using patented AMP technology.
strandls.com2000Bengaluru, India$34.88M532
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
prenetics.com2009Hong Kong, China$67.65M–
Health risks are identified through online genetic and diagnostic testing.
thrivedetect.com2019Cambridge, United States$367M138
Blood-based liquid biopsy tests for multiple cancer detection are provided.
veracyte.com2008San Francisco, United States$67.9M815
Genomics-based diagnostic tests for cancer are developed.
delfidiagnostics.com2019Baltimore, United States$331.59M–
Provider of DNA sequencing for cancer detection
Premium access

Detailed competitors of Sapere Bio

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Sapere Bio

Websites that share an audience with Sapere Bio (saperebio.com).

Similar websites

Websites whose visitors overlap most with Sapere Bio. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
altisbiosystems.com
100%
16.6K#1,779,798View details
catawbaresearch.com
100%
3.5K#5,071,999View details
lifeeditinc.com
97%
––View details
xilis.com
94%
2.5K#6,836,474View details
kriyatherapeutics.com
76%
8.3K#2,376,825View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 6 similar websites and full traffic analytics for Sapere Bio

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Similar companies to Sapere Bio

10 companies that operate in the same segment as Sapere Bio (Dermatology), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
2002Newark, New Jersey, United StatesUSD 154.56 MUSD 234.04 M597
Diagnostic tests for cancer prognosis are provided.
2008Friendswood, Texas, United StatesUSD 61.97 MUSD 344.23 M761
Developer of drugs for treating dermatology diseases
1908Copenhagen, DenmarkUSD 560.38 M––
Skincare, beauty, and wellness services provided by VLCC across multiple countries.
1989Delhi, Delhi, India–––
Adhesive patch biopsies for skin cancer detection are provided.
1996San Diego, California, United StatesUSD 24.37 MUSD 15.3 M259
AI-powered drug discovery platform for various diseases
2016New York, New York, United StatesUSD 608 M––
Immunotherapeutic solutions for dermatological conditions are developed.
2016Westlake Village, California, United StatesUSD 94.5 MUSD 376.07 M342
Targeted small molecules are developed for oncology treatments.
2010Singapore, SingaporeUSD 100 M––
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured.
2014Pune, Maharashtra, IndiaUSD 25.97 MUSD 18.15 M508
Novel dermatologic therapies are developed for skin conditions.
2012Malvern, Pennsylvania, United StatesUSD 82 MUSD 7.83 M64
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Sapere Bio

Sapere Bio was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Sapere Bio is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.

Natalia Mitin is the current CEO of Sapere Bio. They have also founded this company.

Sapere Bio is a funded company, having raised a total of $500K across 5 funding rounds to date. The company's 1st funding round was a Grant of $121.64K, raised on Sep 2014.

Founded in 2013 and based in Raleigh, United States, Sapere Bio operates in the life sciences sector, focusing on diagnostic tests for biological age assessment. Cellular senescence and immune system functions are analyzed to identify chronic disease risks. Actionable health insights are provided to healthcare professionals through these biomarker-based services, supporting personalized medicine approaches.

Sapere Bio's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.

Sapere Bio has 1 investor. Key investors include HHS.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available